US Patent Issued to PACYLEX PHARMACEUTICALS on July 1 for "Synthetic lethality and the treatment of cancer" (Canadian, French Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,341, issued on July 1, was assigned to PACYLEX PHARMACEUTICALS INC. (Calgary, Canada).

"Synthetic lethality and the treatment of cancer" was invented by Luc G. Berthiaume (Edmonton, Canada), Erwan Beauchamp (Rennes, France), Conganige Maneka Anne Perinpanayagam (Edmonton, Canada) and Chuiyee Yap (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein. In one aspect of the present invention, ther...